Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.71 USD | +1.85% | +18.08% | +30.53% |
07:25pm | Cogent Biosciences Q1 Loss Widens | MT |
02:26pm | Cogent Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+30.53% | 724M | |
+9.88% | 106B | |
+0.95% | 104B | |
+6.72% | 23.25B | |
-13.83% | 22.5B | |
-6.64% | 18.7B | |
-37.26% | 17.95B | |
-10.79% | 16.99B | |
+8.25% | 14.26B | |
+39.83% | 12.76B |
- Stock Market
- Equities
- COGT Stock
- News Cogent Biosciences, Inc.
- Baird Downgrades Cogent Biosciences to Neutral From Outperform, Adjusts Price Target to $8 From $14